García Alonso L - Search Results

1

Acute myeloid leukemia M2 and t(8;21)(q22;q22) with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-), and CD33(-).

García Vela JA, Martin M, Delgado I, García Alonso L, Monteserin MC, Benito L, Somolinos N, Oña F. García Vela JA, et al. Among authors: garcia alonso l. Ann Hematol. 1999 May;78(5):237-40. doi: 10.1007/s002770050508. Ann Hematol. 1999. PMID: 10391105

2

CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection.

Garcia Vela J, Delgado I, Benito L, Monteserin M, Garcia Alonso L, Somolinos N, Andreu M, Oña F. Garcia Vela J, et al. Among authors: garcia alonso l. Leukemia. 1999 Oct;13(10):1501-5. doi: 10.1038/sj.leu.2401511. Leukemia. 1999. PMID: 10516749

3

The utility of multiparametric flow cytometry in the detection of primary effusion lymphoma (PEL).

Galán J, Martin I, Carmona I, Rodriguez-Barbero JM, Cuadrado E, García-Alonso L, García-Vela JA. Galán J, et al. Among authors: garcia alonso l, garcia vela ja. Cytometry B Clin Cytom. 2019 Sep;96(5):375-378. doi: 10.1002/cyto.b.21637. Epub 2018 May 10. Cytometry B Clin Cytom. 2019. PMID: 29669178 Free article.

4

Detection of minimal residual disease in B-cell chronic lymphocytic leukaemia by flow cytometry.

García Vela JA, Delgado I, García Alonso L, Monteserin MC, Benito L, Oña F, Lastra AM. García Vela JA, et al. Among authors: garcia alonso l. Br J Haematol. 1997 Nov;99(2):464-5. doi: 10.1046/j.1365-2141.1997.d01-3651.x. Br J Haematol. 1997. PMID: 9375774 Free article. No abstract available.

5

Hairy cell leukemia, blastic type: description of spleen morphology and immunophenotype of a distinctive case.

Kanellis G, Garcia-Alonso L, Camacho FI, Garcia JF, Mollejo M, Montes-Moreno S, Garcia-Vela JA, Piris MA. Kanellis G, et al. Among authors: garcia alonso l, garcia jf, garcia vela ja. Leuk Lymphoma. 2011 Aug;52(8):1589-92. doi: 10.3109/10428194.2011.575488. Epub 2011 May 3. Leuk Lymphoma. 2011. PMID: 21534875 No abstract available.

6

Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.

Font P, Loscertales J, Soto C, Ricard P, Novas CM, Martín-Clavero E, López-Rubio M, Garcia-Alonso L, Callejas M, Bermejo A, Benavente C, Ballesteros M, Cedena T, Calbacho M, Urbina R, Villarrubia J, Gil S, Bellón JM, Diez-Martin JL, Villegas A. Font P, et al. Among authors: garcia alonso l. Ann Hematol. 2015 Apr;94(4):565-73. doi: 10.1007/s00277-014-2252-4. Epub 2014 Nov 13. Ann Hematol. 2015. PMID: 25387664

7

Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification.

Font P, Loscertales J, Benavente C, Bermejo A, Callejas M, Garcia-Alonso L, Garcia-Marcilla A, Gil S, Lopez-Rubio M, Martin E, Muñoz C, Ricard P, Soto C, Balsalobre P, Villegas A. Font P, et al. Among authors: garcia alonso l, garcia marcilla a. Ann Hematol. 2013 Jan;92(1):19-24. doi: 10.1007/s00277-012-1565-4. Epub 2012 Sep 5. Ann Hematol. 2013. PMID: 22948274

8

[Cytogenetic risk categories in acute myeloid leukemia: a comparison between MRC (Medical Research Council) and SWOG (Southwest Oncology Group) models)].

Martín Ramos ML, López Pastor M, de la Serna Torroba J, Ayala R, García Alonso L, Barreiro Miranda E. Martín Ramos ML, et al. Among authors: garcia alonso l. Med Clin (Barc). 2003 Jun 28;121(4):121-5. Med Clin (Barc). 2003. PMID: 12867014 Spanish.

9

Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases.

Rapado I, Albizua E, Ayala R, Hernández JA, Garcia-Alonso L, Grande S, Gallardo M, Gilsanz F, Martinez-Lopez J. Rapado I, et al. Among authors: garcia alonso l. Ann Hematol. 2008 Sep;87(9):741-9. doi: 10.1007/s00277-008-0512-x. Epub 2008 Jun 25. Ann Hematol. 2008. PMID: 18575865

10

The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients.

Paiva B, Vidriales MB, Mateo G, Pérez JJ, Montalbán MA, Sureda A, Montejano L, Gutiérrez NC, García de Coca A, de las Heras N, Mateos MV, López-Berges MC, García-Boyero R, Galende J, Hernández J, Palomera L, Carrera D, Martínez R, de la Rubia J, Martín A, González Y, Bladé J, Lahuerta JJ, Orfao A, San-Miguel JF; GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Groups. Paiva B, et al. Blood. 2009 Nov 12;114(20):4369-72. doi: 10.1182/blood-2009-05-221689. Epub 2009 Sep 15. Blood. 2009. PMID: 19755674 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters